587 results on '"MS Interne Geneeskunde"'
Search Results
2. Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review
3. Age at cardiovascular disease onset, dementia risk, and the role of lifestyle factors
4. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis
5. Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen
6. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
7. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort
8. Association of body mass index and waist circumference with long-term mortality risk in 10,370 coronary patients and potential modification by lifestyle and health determinants
9. Prevalence and determinants of self-reported low-fat-, low-salt-, and vegetarian diets in patients with cardiovascular disease between 1996 and 2019
10. Thinner inner retinal layers are associated with lower cognitive performance, lower brain volume, and altered white matter network structure-The Maastricht Study
11. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
12. Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts
13. Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease
14. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC
15. Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial
16. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
17. Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease
18. The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial
19. Diagnostic yield of molecular diagnostics for the atypical pathogens: diagnostic stewardship is warranted
20. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
21. Differences in checkpoint-inhibitor-induced hypophysitis: mono- versus combination therapy induced hypophysitis
22. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis
23. Dietary habits and compliance with dietary guidelines in patients with established cardiovascular disease
24. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding—“This pill will keep you alive tonight”
25. HbA1cand fasting plasma glucose levels are equally related to incident cardiovascular risk in a high CVD risk population without known diabetes
26. Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysis
27. Origins and Previous Applications of Causal-Benefit Models
28. Association of physical activity and sports participation with insulin resistance and non-alcoholic fatty liver disease in people with type 1 diabetes
29. Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis
30. Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
31. Potency of quality indicators in Dutch and international diabetes registries
32. Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and Finland
33. Call for effective therapies for preventing dementia in people with type 2 diabetes
34. Mortality patterns in Dutch diabetes outpatients
35. The Natural Course of Arterial Calcifications in Pseudoxanthoma Elasticum: A Prospective Cohort Study
36. Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational Study
37. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)
38. Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET)
39. No Evidence for an Association of HIV and Antiviral Treatment With Changes in Framingham Cardiovascular Risk Score in the Ndlovu Cohort Study
40. Potential impact of a new sepsis prediction model for the primary care setting: early health economic evaluation using an observational cohort
41. Microvascular Dysfunction and Whole-Brain White Matter Connectivity: The Maastricht Study
42. Updated Prevalence of Lymphangioleiomyomatosis in Europe
43. Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controls
44. Association between lower extremity arterial calcification and coronary arterial calcification in a population at increased risk of cardiovascular disease
45. Intracranial arteriosclerosis and the risk of dementia: A population-based cohort study
46. Do pseudoxanthoma elasticum patients have higher prevalence of kidney stones on computed tomography compared to hospital controls?
47. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study
48. Long-term lifestyle change and risk of mortality and type 2 diabetes in patients with cardiovascular disease
49. Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency
50. Trends in body mass index in the pre-dolutegravir period in South Africa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.